Clinical Trial Update: Immediate Versus Delayed Treatment With Azathioprine or Rituximab in Anti-MOG Antibodies Associated Acute Demyelinating Syndromes in Children: a Randomized Controlled Clinical Trial [Phase 3]

View source ↗

Summary

Phase 3 randomized trial assessing immediate versus delayed treatment with azathioprine or rituximab for anti-MOG antibody-associated acute demyelinating syndro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mog Antibody-associated Disease

Drugs mentioned

• Azathioprine (azathioprine)
• Rituximab (rituximab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Demyelinating Syndrome | Phase 3 | Status: RECRUITING